City

Almaty (1)

Hanoi (1)

Ho Chi Minh City (1)

Karachi (1)

Kotri (1)

Lima (1)

Maseru (1)

Nur-Sultan (1)

Pune (1)

Condition

Bacterial Infections (1)

Gram-Positive Bacterial Infections (1)

Mycobacterial Infections (1)

Pulmonary Tuberculoses (1)

Tuberculosis (1)

Tuberculosis, Multidrug-Resistant (1)

Overall Status

Recruiting (1)

Phase

phase 3 (1)

Sponsor

Medecins Sans Frontieres, France (1)

Collaborator

Epicentre (1)

Harvard Medical School (HMS and HSDM) (1)

Institute of Tropical Medicine, Belgium (1)

Interactive Research and Development (1)

Partners in Health (1)

Socios En Salud, Peru (1)

University of San Francisco (1)

Intervention

bedaquiline 100 mg (1)

clofazimine 100 mg oral capsule (1)

control arm mdr-tb regimen, designed according to latest who guidelines (1)

delamanid 50 mg oral tablet (1)

linezolid 600mg tab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

mycobacterial infections

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

Recruiting

Tuberculosis, Multidrug-Resistant
+5 more

Bedaquiline 100 MG
+4 more

Pune, India
+9 more

Mar 2, 2022